Keane C - Search Results

1

Keane C, Colreavy M, Lynch M, O'Gorman P. Keane C, et al. Am J Hematol. 2009 Feb;84(2):123. doi: 10.1002/ajh.21167. Am J Hematol. 2009. PMID: 19253415 Free article. No abstract available.

2

Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma.

Jones K, Nourse JP, Keane C, Crooks P, Gottlieb D, Ritchie DS, Gill D, Gandhi MK. Jones K, et al. Among authors: keane c. Am J Hematol. 2012 Mar;87(3):258-65. doi: 10.1002/ajh.22252. Epub 2011 Dec 27. Am J Hematol. 2012. PMID: 22213215 Free article.

3

CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy.

Keane C, Gill D, Vari F, Cross D, Griffiths L, Gandhi M. Keane C, et al. Am J Hematol. 2013 Apr;88(4):273-6. doi: 10.1002/ajh.23398. Epub 2013 Mar 5. Am J Hematol. 2013. PMID: 23460351 Free article.

4

Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma.

Keane C, Nourse JP, Crooks P, Nguyen-Van D, Mutsando H, Mollee P, Lea RA, Gandhi MK. Keane C, et al. Intern Med J. 2012 Oct;42(10):1113-9. doi: 10.1111/j.1445-5994.2011.02587.x. Intern Med J. 2012. PMID: 21883784

5

The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization.

Keane C, Gibbs S, Seymour JF, Mills AK, Grimmett K, Van Kuilenberg R, Saal R, Gill D, Prince HM, Marlton P, Mollee P. Keane C, et al. Hematol Oncol. 2006 Sep;24(3):159-63. doi: 10.1002/hon.784. Hematol Oncol. 2006. PMID: 16775841

6

Myeloid and lymphoid neoplasm with FGFR1 abnormality.

Keane C, Henden A, Mills T, Wood P. Keane C, et al. Br J Haematol. 2009 May;145(4):440. doi: 10.1111/j.1365-2141.2008.07480.x. Epub 2008 Dec 8. Br J Haematol. 2009. PMID: 19076174 Free article. No abstract available.

7

Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma.

Jones K, Nourse JP, Keane C, Bhatnagar A, Gandhi MK. Jones K, et al. Among authors: keane c. Clin Cancer Res. 2014 Jan 1;20(1):253-64. doi: 10.1158/1078-0432.CCR-13-1024. Epub 2013 Nov 12. Clin Cancer Res. 2014. PMID: 24222179

8

Neutrophil phagocytosis of Klebsiella pneumoniae.

Keane C, Prout B, Bird R. Keane C, et al. Br J Haematol. 2008 Sep;142(5):682. doi: 10.1111/j.1365-2141.2008.07213.x. Epub 2008 May 19. Br J Haematol. 2008. PMID: 18492120 Free article. No abstract available.

9

The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma.

Keane C, Gould C, Jones K, Hamm D, Talaulikar D, Ellis J, Vari F, Birch S, Han E, Wood P, Le-Cao KA, Green MR, Crooks P, Jain S, Tobin J, Steptoe RJ, Gandhi MK. Keane C, et al. Clin Cancer Res. 2017 Apr 1;23(7):1820-1828. doi: 10.1158/1078-0432.CCR-16-1576. Epub 2016 Sep 20. Clin Cancer Res. 2017. PMID: 27649554

10

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration.

Tobin JWD, Keane C, Gunawardana J, Mollee P, Birch S, Hoang T, Lee J, Li L, Huang L, Murigneux V, Fink JL, Matigian N, Vari F, Francis S, Kridel R, Weigert O, Haebe S, Jurinovic V, Klapper W, Steidl C, Sehn LH, Law SC, Wykes MN, Gandhi MK. Tobin JWD, et al. Among authors: keane c. J Clin Oncol. 2019 Dec 1;37(34):3300-3309. doi: 10.1200/JCO.18.02365. Epub 2019 Aug 28. J Clin Oncol. 2019. PMID: 31461379 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

403 results

Search Page